Bin-Kui Li (Binkui Li)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Metastatic Colorectal Cancer

Ejection Fraction

Radiofrequency Ablation

Top Venues

Cancer medicine

Alimentary pharmacology & therapeutics

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Keren Li, Yi Niu, Kai Li, Chengrui Zhong, Zhiyu Qiu, Yichuan Yuan, Yunxing Shi, Zhu Lin, Zhenkun Huang, Dinglan Zuo, Yichuan Yuan, Bin-Kui Li
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma. Journal of clinical and translational hepatology 11 (5) (2023)
Wei He, Bin-Kui Li, Yichuan Yuan
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Alimentary pharmacology & therapeutics 57 (1) (2022)
Wei He, Bin-Kui Li, Yichuan Yuan
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Alimentary pharmacology & therapeutics 57 (1) (2022)
Kai Li, Yi Niu, Yichuan Yuan, Jiliang Qiu, Yunxing Shi, Chengrui Zhong, Zhiyu Qiu, Keren Li, Zhu Lin, Zhenkun Huang, Chao Zhang, Dinglan Zuo, Wei He, Yichuan Yuan, Bin-Kui Li
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling. Oncogene 41 (23) (2022)
Wei He, Bin-Kui Li, Yichuan Yuan
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Alimentary pharmacology & therapeutics 57 (1) (2022)
Ling-Min Jiang, Yuan-Ping Zhang, Chen-Wei Wang, Wei-Dong Zhang, Wei He, Ji-Liang Qiu, Yi-Chuan Yuan, Bin-Kui Li, Yichuan Yuan, Ren-Chun Lai, Dan Dan Hu, Yun Zheng
More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation. Journal of oncology 2022 (2022)